Abstract
The Epstein–Barr virus is etiologically linked with the development of benign and malignant diseases, characterized by their diversity and a heterogeneous geographic distribution across the world. The virus possesses a 170-kb-large genome that encodes for multiple proteins and non-coding RNAs. Early on there have been numerous attempts to link particular diseases with particular EBV strains, or at least with viral genetic polymorphisms. This has given rise to a wealth of information whose value has been difficult to evaluate for at least four reasons. First, most studies have looked only at one particular gene and missed the global picture. Second, they usually have not studied sufficient numbers of diseased and control cases to reach robust statistical significance. Third, the functional significance of most polymorphisms has remained unclear, although there are exceptions such as the 30-bp deletion in LMP1. Fourth, different biological properties of the virus do not necessarily equate with a different pathogenicity. This was best illustrated by the type 1 and type 2 viruses that markedly differ in terms of their transformation abilities, yet do not seem to cause different diseases. Reciprocally, environmental and genetic factors in the host are likely to influence the outcome of infections with the same virus type. However, with recent developments in recombinant virus technology and in the availability of high throughput sequencing, the tide is now turning. The availability of 23 complete or nearly complete genomes has led to the recognition of viral subtypes, some of which possess nearly identical genotypes. Furthermore, there is growing evidence that some genetic polymorphisms among EBV strains markedly influence the biological and clinical behavior of the virus. Some virus strains are endowed with biological properties that explain crucial clinical features of patients with EBV-associated diseases. Although we now have a better overview of the genetic diversity within EBV genomes, it has also become clear that defining phenotypic traits evinced by cells infected by different viruses usually result from the combination of multiple polymorphisms that will be difficult to identify in their entirety. However, the steadily increasing number of sequenced EBV genomes and cloned EBV BACS from diseased and healthy patients will facilitate the identification of the key polymorphisms that condition the biological and clinical behavior of the viruses. This will allow the development of preventative and therapeutic approaches against highly pathogenic viral strains.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- BAC:
-
Bacterial artificial chromosomes
- BL:
-
Burkitt’s lymphoma
- EBV:
-
Epstein–Barr Virus
- EBNA:
-
Epstein–Barr virus nuclear antigen
- LMP:
-
Latent membrane protein
- miRNAs:
-
MicroRNAs
- NGS:
-
Next-generation sequencing
- NPC:
-
Nasopharyngeal carcinoma
- RFLP:
-
Restriction fragment length polymorphism
- PTLD:
-
Posttransplant lymphoproliferative disorder
References
Abdel-Hamid M, Chen JJ, Constantine N, Massoud M, Raab-Traub N (1992) EBV strain variation: geographical distribution and relation to disease state. Virology 190:168–175
Adldinger HK, Delius H, Freese UK, Clarke J, Bornkamm GW (1985) A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:221–234
Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB (1994) Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol 75(Pt 1):95–100
Apolloni A, Sculley TB (1994) Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 202:978–981
Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C et al (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211
Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, Magrath IT (1996) Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt’s lymphomas. Oncogene 13:177–181
Boyle MJ, Vasak E, Tschuchnigg M, Turner JJ, Sculley T, Penny R, Cooper DA, Tindall B, Sewell WA (1993) Subtypes of Epstein-Barr virus (EBV) in Hodgkin’s disease: association between B-type EBV and immunocompromise. Blood 81:468–474
Burrows JM, Burrows SR, Poulsen LM, Sculley TB, Moss DJ, Khanna R (1996) Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. J Virol 70:2490–2496
Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K (2009) The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res 143:209–221
Chen JN, He D, Tang F, Shao CK (2012) Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. J Clin Gastroenterol 46:262–271
Cheung ST, Lo KW, Leung SF, Chan WY, Choi PH, Johnson PJ, Lee JC, Huang DP (1996) Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer 66:711–712
Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86:9558–9562
Cullen BR (2011) Herpesvirus microRNAs: phenotypes and functions. Curr Opin Virol 1:211–215
Dambaugh T, Hennessy K, Chamnankit L, Kieff E (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81:7632–7636
de Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M, Rickinson AB, Masucci MG (1993) HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 260:98–100
de Campos-Lima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG (1994) T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp Med 179:1297–1305
de Jesus O, Smith PR, Spender LC, Elgueta Karstegl C, Niller HH, Huang D, Farrell PJ (2003) Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 84:1443–1450
Delecluse H-J, Feederle R, O’Sullivan B, Taniere P (2007) Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J Clin Pathol 60:1358–1364
Dolan A, Addison C, Gatherer D, Davison AJ, McGeoch DJ (2006) The genome of Epstein-Barr virus type 2 strain AG876. Virology 350:164–170
Edwards RH, Seillier-Moiseiwitsch F, Raab-Traub N (1999) Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261:79–95
Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM (1995) Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 85:1396–1403
Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG (1993) Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 67:1572–1578
Gottschalk S, Ng CY, Perez M, Smith CA, Sample C, Brenner MK, Heslop HE, Rooney CM (2001) An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood 97:835–843
Gratama JW, Ernberg I (1995) Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 67:197–255
Gutierrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, Tsao SW, Yuen PW, Joab I, Magrath IT et al (1997) Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol 78(Pt 7):1663–1670
Gutierrez MI, Ibrahim MM, Dale JK, Greiner TC, Straus SE, Bhatia K (2002) Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J Natl Cancer Inst 94:1757–1763
Habeshaw G, Yao QY, Bell AI, Morton D, Rickinson AB (1999) Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt’s lymphoma reflect virus strains prevalent in different geographic areas. J Virol 73:965–975
Jenkins PJ, Farrell PJ (1996) Are particular Epstein-Barr virus strains linked to disease? Semin Cancer Biol 7:209–215
Jin Y, Xie Z, Lu G, Yang S, Shen K (2010) Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children. Virol J 7:92
Khanna R, Slade RW, Poulsen L, Moss DJ, Burrows SR, Nicholls J, Burrows JM (1997) Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J Virol 71:8340–8346
Kunimoto M, Tamura S, Tabata T, Yoshie O (1992) One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan. J Gen Virol 73(Pt 2):455–461
Kwok H, Tong AH, Lin CH, Lok S, Farrell PJ, Kwong DL, Chiang AK (2012) Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. PLoS ONE 7:e36939
Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK (2014) Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol 88:10662–10672
Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, Esmore D, Sculley TB, Mar Alba M (1992) Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res Hum Retroviruses 8:1869–1874
Lei H, Li T, Hung GC, Li B, Tsai S, Lo SC (2013) Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology. BMC Genom 14:804
Lin Z, Wang X, Strong MJ, Concha M, Baddoo M, Xu G, Baribault C, Fewell C, Hulme W, Hedges D et al (2013) Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains. J Virol 87:1172–1182
Liu P, Fang X, Feng Z, Guo YM, Peng RJ, Liu T, Huang Z, Feng Y, Sun X, Xiong Z et al (2011) Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. J Virol 85:11291–11299
Longnecker RM, Kieff E, Cohen JI (2014) Epstein-Barr virus. In: Knipe DM, Howley PM (eds) Fields of virology, vol 2, 6th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1898–1958
Lorenzetti MA, Gutierrez MI, Altcheh J, Moscatelli G, Moroni S, Chabay PA, Preciado MV (2009) Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: its comparison with pediatric lymphomas. J Med Virol 81:1912–1917
Lorenzetti MAG, Gantuz M, Altcheh J, De Matteo E, Chabay PA, Preciado MV (2012) Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms. J Clin Microbiol 50:609–618
Lorenzetti MA, Gantuz M, Altcheh J, De Matteo E, Chabay PA, Preciado MV (2014) Epstein-Barr virus BZLF1 gene polymorphisms: malignancy related or geographically distributed variants? Clin Microbiol Infect 20:0861–0869
Lung ML, Chang GC, Miller TR, Wara WM, Phillips TL (1994) Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Chinese immigrants to the United States. Int J Cancer 59:743–746
Luo B, Tang X, Jia Y, Wang Y, Chao Y, Zhao C (2011) Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in northern China. Microbes Infect 13:776–782
Mainou BA, Raab-Traub N (2006) LMP1 strain variants: biological and molecular properties. J Virol 80:6458–6468
Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM (2007) Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J Infect 54:298–306
McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, DiCarlo FJ, Chadwick EG, Murphy SB (1995) Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 332:12–18
Midgley RS, Blake NW, Yao QY, Croom-Carter D, Cheung ST, Leung SF, Chan AT, Johnson PJ, Huang D, Rickinson AB et al (2000) Novel intertypic recombinants of Epstein-Barr virus in the chinese population. J Virol 74:1544–1548
Midgley RS, Bell AI, McGeoch DJ, Rickinson AB (2003a) Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J Virol 77:11517–11530
Midgley RS, Bell AI, Yao QY, Croom-Carter D, Hislop AD, Whitney BM, Chan AT, Johnson PJ, Rickinson AB (2003b) HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. J Virol 77:11507–11516
Kieff E, Rickinson, AB (2007) Epstein-Barr virus and its replication. In: Knipe DM, Howley PM (eds) Fields virology, 5th ed. Lippincott Williams and Wilkins, Philadelphia, pp 2603–2654
Rickinson AB, Kieff E (2007) Epstein-Barr virus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Fields virology, vol 2, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 2655–2700
Rickinson AB, Young LS, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 61:1310–1317
Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB (1989) Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J Virol 63:1031–1039
Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E (1990) Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64:4084–4092
Sandvej K, Gratama JW, Munch M, Zhou XG, Bolhuis RL, Andresen BS, Gregersen N, Hamilton-Dutoit S (1997) Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 90:323–330
Santpere G, Darre F, Blanco S, Alcami A, Villoslada P, Mar Alba M, Navarro A (2014) Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project. Genome Biol Evol 6:846–860
Sawada A, Croom-Carter D, Kondo O, Yasui M, Koyama-Sato M, Inoue M, Kawa K, Rickinson AB, Tierney RJ (2011) Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family. J Gen Virol 92:1032–1043
Schuster V, Ott G, Seidenspinner S, Kreth HW (1996) Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Blood 87:1579–1585
Sculley TB, Sculley DG, Pope JH, Bornkamm GW, Lenoir GM, Rickinson AB (1988a) Epstein-Barr virus nuclear antigens 1 and 2 in Burkitt lymphoma cell lines containing either ‘A’- or ‘B’-type virus. Intervirology 29:77–85
Sculley TB, Cross SM, Borrow P, Cooper DA (1988b) Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus. J Infect Dis 158:186–192
Sculley TB, Apolloni A, Stumm R, Moss DJ, Mueller-Lantczh N, Misko IS, Cooper DA (1989) Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus. Virology 171:401–408
Shu CH, Chang YS, Liang CL, Liu ST, Lin CZ, Chang P (1992) Distribution of type A and type B EBV in normal individuals and patients with head and neck carcinomas in Taiwan. J Virol Methods 38:123–130
Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L (1989) Detection of a second widespread strain of Epstein-Barr virus. Lancet 2:761–765
Sung NSE, Edwards RH, Seillier-Moiseiwitsch F, Perkins AG, Zeng Y, Raab-Traub N (1998) Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int J Cancer 76:207–215
Tong JH, Lo KW, Au FW, Huang DP (2003) To KF: Re: Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J Natl Cancer Inst 95:1008–1009 (author reply 1009)
Tsai MH, Raykova A, Klinke O, Bernhardt K, Gärtner K, Leung CS, Geletneky K, Sertel S, Münz C, Feederle R, Delecluse HJ (2013) Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep 5:458–470
van Baarle D, Hovenkamp E, Dukers NH, Renwick N, Kersten MJ, Goudsmit J, Coutinho RA, Miedema F, van Oers MH (2000) High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. J Infect Dis 181:2045–2049
White RE, Ramer PC, Naresh KN, Meixlsperger S, Pinaud L, Rooney C, Savoldo B, Coutinho R, Bodor C, Gribben J et al (2012) EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest 122:1487–1502
Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757–768
Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB (1987) New type B isolates of Epstein-Barr virus from Burkitt’s lymphoma and from normal individuals in endemic areas. J Gen Virol 68(Pt 11):2853–2862
Yu XM, McCarthy PJ, Wang Z, Gorlen DA, Mertz JE (2012) Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus. J Virol 86:8086–8096
Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, Yu XJ, Wang HM, Ernberg I, Zeng YX (2005) Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol 79:15323–15330
Zimber U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U et al (1986) Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56–66
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Feederle, R., Klinke, O., Kutikhin, A., Poirey, R., Tsai, MH., Delecluse, HJ. (2015). Epstein–Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Types. In: Münz, C. (eds) Epstein Barr Virus Volume 1. Current Topics in Microbiology and Immunology, vol 390. Springer, Cham. https://doi.org/10.1007/978-3-319-22822-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-22822-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22821-1
Online ISBN: 978-3-319-22822-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)